Am Heart J

1. PUNDI K, Gandotra C, Sanders W, Senatore F, et al
   Considerations for Using Atrial Fibrillation Burden as a Surrogate Endpoint A Report from the Cardiovascular Sciences Research Consortium.
   Am Heart J. 2026 Jun 22:107516. doi: 10.1016/j.ahj.2026.107516.
   

   >> Share

   
   
2. MURO FMD, Raona V, Sartori S, Smith K, et al
   Prognostic Impact of Combined Inflammatory Markers in Patients Undergoing Percutaneous Coronary Intervention.
   Am Heart J. 2026 Jun 21:107519. doi: 10.1016/j.ahj.2026.107519.
   

   >> Share

   
   

   
   Am J Cardiol

3. BC A, Rao SN, M M, V VA, et al
   Retinal Microvascular Signatures as Early Predictors of Cardiovascular Risk: Integrating Pathophysiology, Molecular Insights, and Artificial Intelligence.
   Am J Cardiol. 2026 Jun 19:S0002-9149(26)00411.
   

   >> Share

   
   
4. ABBAS OF, Emara A, Almarfadi A, Haddad R, et al
   Fractional Flow Reserve-Guided Versus Coronary Angiography Alone for Guiding Coronary Artery Bypass Grafting: A Meta-Analysis of Randomized Trials.
   Am J Cardiol. 2026 Jun 21:S0002-9149(26)00419.
   

   >> Share

   
   
5. MUHAMMAD A, Razdan P, LaLonde TA
   Effect of Prior Coronary Artery Disease on Troponin Kinetics and Its Prognostic Association in Acute Pulmonary Embolism.
   Am J Cardiol. 2026 Jun 23:S0002-9149(26)00414.
   

   >> Share

   
   
6. NAKATA Y, Shibahashi E, Otsuki H, Arashi H, et al
   Prognostic Utility of the BCIS-CHIP Score in Imaging-Guided Percutaneous Coronary Intervention.
   Am J Cardiol. 2026 Jun 23:S0002-9149(26)00416.
   

   >> Share

   
   
7. SURUAGY-MOTTA RFO, da Silva LD, Rosa CR, Barbosa GLV, et al
   Drug-Coated Balloons versus Drug-Eluting Stents following Coronary Atherectomy in Severely Calcified Lesions: A Systematic Review and Meta-Analysis.
   Am J Cardiol. 2026 Jun 25:S0002-9149(26)00429.
   

   >> Share

   
   
8. SANGIORGI GM, Benedetto D, Massaro G, Marchetta M, et al
   Drug-Eluting Balloons Versus Drug-Eluting Stents for De Novo Coronary Lesions With Large-vessel Focus: A Narrative Review.
   Am J Cardiol. 2026;271:47-53.
   

   >> Share

   
   
9. NISHIMIYA K, Yosofi B, Dimitriu-Leen AC, Volleberg RHJA, et al
   Feasibility and Yield of a Diagnostic Protocol for Myocardial Infarction with Non-Obstructive Coronary Arteries.
   Am J Cardiol. 2026 Jun 24:S0002-9149(26)00428.
   

   >> Share

   
   
10. INUTSUKA K, Shibahashi E, Otsuki H, Arashi H, et al
    Prehospital Statin Therapy and Outcomes in ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Am J Cardiol. 2026 Jun 25:S0002-9149(26)00434.
    

    >> Share

    
    

    
    Am J Med

11. LIM Y
    Night-Shift Intensity, Duration, Cardiovascular Susceptibility and Incident Cardiovascular Disease: UK Biobank Study.
    Am J Med. 2026 Jun 22:S0002-9343(26)00494-8. doi: 10.1016/j.amjmed.2026.
    

    >> Share

    
    

    
    Am J Public Health

12. FORT MP, Haapanen KA, Aulakh A, Moreland J, et al
    Assessing Cardiovascular Disease Prevention Activities in the Denver, Colorado, Metropolitan Area: Building on an Existing Network to Enhance Emphasis on Equity.
    Am J Public Health. 2026;116.
    

    >> Share

    
    

    
    Angiology

13. DAOULAH A, Elmahrouk A, Lotfi A
    Response to the Letter to the Editor: "Effect of Invasive Hemodynamic Monitoring on the Outcomes of Cardiogenic Shock in Patients With Acute Myocardial Infarction".
    Angiology. 2026 Jun 22:33197261464009. doi: 10.1177/00033197261464009.
    

    >> Share

    
    
14. ANG SP, Chia JE, Krittanawong C, Mukherjee D, et al
    Racial Differences in the Trends, Clinical Characteristics and Outcomes of Patients Undergoing Coronary Atherectomy.
    Angiology. 2026;77:844-856.
    

    >> Share

    
    

    
    Ann Thorac Surg

15. CATALANO MA, Zhao Y, Toubat O, Shin M, et al
    Inpatient versus delayed readmission for coronary artery bypass grafting following non-ST elevation myocardial infarction.
    Ann Thorac Surg. 2026 Jun 19:S0003-4975(26)00578.
    

    >> Share

    
    

    
    Arterioscler Thromb Vasc Biol

16. SCHNEIDER M, Skoglund C, Chung RWS, Jonasson L, et al
    Neutrophils Exhibit Delayed Spontaneous Apoptosis and Resistance to Regulatory T-Cell-Induced Apoptosis in Patients With Chronic Coronary Syndrome: Brief Report.
    Arterioscler Thromb Vasc Biol. 2026 Jun 25. doi: 10.1161/ATVBAHA.126.324652.
    

    >> Share

    
    
17. KARIM S, Khan S, Somers VK
    Sleep, Neural Circulatory Control, and Cardiovascular Disease: A Mechanistic Review.
    Arterioscler Thromb Vasc Biol. 2026 Jun 25. doi: 10.1161/ATVBAHA.125.324076.
    

    >> Share

    
    
18. MORIHARA C, Benavente K, Park C, Hassan Virk HU, et al
    Financial Toxicity: Inequities and Impact on Cardiovascular Disease.
    Arterioscler Thromb Vasc Biol. 2026 Jun 25. doi: 10.1161/ATVBAHA.125.324015.
    

    >> Share

    
    
19. LI L, Zhang Y, Truong B, Yu Z, et al
    Endothelial Susceptibility-Related Genetic Variants and Hypertensive Disorders of Pregnancy-Brief Report.
    Arterioscler Thromb Vasc Biol. 2026;46:e324519.
    

    >> Share

    
    

    
    Atherosclerosis

20. KERNISS H, Olbrich H, Curman P, Stander S, et al
    Pyoderma gangrenosum is associated with excess incident major atherothrombotic events.
    Atherosclerosis. 2026;418:120801.
    

    >> Share

    
    

    
    Can J Cardiol

21. ZHANG M, Zou Y, Ruan H, Chen Y, et al
    Activation of Endothelial TRPV4 Exacerbates Myocardial Ischemia-Reperfusion Injury via Vascular Integrity Impairment.
    Can J Cardiol. 2026;42:1353-1365.
    

    >> Share

    
    
22. SU Y, Mei J, Ye R, Pan X, et al
    Predicting Midterm Risk of Coronary Plaque Progression in Subclinical Nonobstructive Coronary Atherosclerosis Using Explainable Machine Learning.
    Can J Cardiol. 2026;42:1140-1157.
    

    >> Share

    
    
23. MANTELLA LE, Colledanchise KN, Liblik K, Hetu MF, et al
    Carotid Plaque Border Ulceration is Associated With Coronary Artery Disease and Future Cardiovascular Events.
    Can J Cardiol. 2026;42:1237-1246.
    

    >> Share

    
    
24. BOGNER E, Har B, Li B, Southern DA, et al
    Comprehensive Machine Learning-Enabled Outcome Prediction for Patients With Coronary Artery Disease Using Multicentre Patient Data.
    Can J Cardiol. 2026;42:1384-1396.
    

    >> Share

    
    
25. SONG JE, Yang HM, Kang J, Hwang D, et al
    Long-Term Clopidogrel vs Aspirin Monotherapy in coronary artery disease patients with High Ischemic Risk: HOST-EXAM Extended Study Post Hoc Analysis.
    Can J Cardiol. 2025 Dec 24:S0828-282X(25)01576.
    

    >> Share

    
    
26. BOIVIN-PROULX LA, Schampaert E, Bainey K, Chong AY, et al
    Defining Metrics and the Framework for the Invasive Assessment of Patients With Presumed Coronary Microvascular and Vasomotor Dysfunction.
    Can J Cardiol. 2026;42:1169-1180.
    

    >> Share

    
    
27. BOIVIN-PROULX LA, Schampaert E, Bainey K, Chong AY, et al
    A Standardized Invasive Protocol for the Investigation of Patients With Presumed Coronary Microvascular and Vasomotor Dysfunction.
    Can J Cardiol. 2026;42:1181-1189.
    

    >> Share

    
    
28. BOIVIN-PROULX LA, Schampaert E, Bainey K, Chong AY, et al
    Defining Population at Risk and Assessment of Patients With Presumed Coronary Microvascular and Vasomotor Dysfunction.
    Can J Cardiol. 2026;42:1158-1168.
    

    >> Share

    
    
29. KAY RT, Perka J, Sidhu A, Zheng Y, et al
    Impact of Baseline Q Waves and Reperfusion Strategy on Outcomes in ST-elevation Myocardial Infarction: Insights from the Vital Heart Response Registry.
    Can J Cardiol. 2026 Jun 23:S0828-282X(26)00635.
    

    >> Share

    
    

    
    Cardiovasc Res

30. SCHNECKMANN R, Hube T, Darakchieva V, Zardkouhi A, et al
    Cell migration inducing protein alleviates adverse cardiac remodelling after ischaemia and reperfusion injury by controlling fibroblast activation.
    Cardiovasc Res. 2026;122:1243-1256.
    

    >> Share

    
    
31. REDONDO-RODRIGUEZ A, Quintanilla JG, Macias A, Lee P, et al
    Ventricular fibrillation dynamics reveal regional asymmetry in resilience to cardiac arrest and predict clinical outcome.
    Cardiovasc Res. 2026 May 28:cvag101. doi: 10.1093.
    

    >> Share

    
    
32. BJORKBACKA H, Goncalves I, Engstrom G, Schiopu A, et al
    Associations of the inflammasome-dependent cytokine IL-18 with risk of coronary heart disease.
    Cardiovasc Res. 2026 Jun 23:cvag135. doi: 10.1093.
    

    >> Share

    
    
33. ABOU ZAKI R, El-Osta A
    Urea-cycle control of fibroblast energetics after myocardial infarction.
    Cardiovasc Res. 2026 Jun 25:cvag127. doi: 10.1093.
    

    >> Share

    
    

    
    Circulation

34. MO D, Dai H
    Why We Must Rethink Universal Lp(a) Screening as a Routine Cardiovascular Prevention Strategy.
    Circulation. 2026;153:1949-1951.
    

    >> Share

    
    

    
    Clin Cardiol

35. NAMAN T, Zhang YT, Maihemuti A, Cheng H, et al
    Evaluate the Prognostic Value of serumgammaKlotho on Long-Term Prognosis of Patients With Multivessel Coronary Artery Disease and Establish a Prognostic Model.
    Clin Cardiol. 2026;49:e70393.
    

    >> Share

    
    
36. CHEEMA AAA, Gulzar AHB, Zehra M, Cheema AA, et al
    Trends and Disparities in Acute Myocardial Infarction-Related Mortality With Co-Listed Nicotine Dependence in the United States, 1999-2020.
    Clin Cardiol. 2026;49:e70392.
    

    >> Share

    
    

    
    Eur Heart J

37. GOVIND A
    Peri-operative myocardial infarction after non-cardiac surgery: validating the case for cardiologist involvement while acknowledging what remains unresolved.
    Eur Heart J. 2026 Jun 19:ehag473. doi: 10.1093.
    

    >> Share

    
    
38. PUELACHER C, Glarner N, Mueller C
    Despite uncertainty, cardiologist involvement in care of perioperative myocardial infarction/injury appears reasonable.
    Eur Heart J. 2026 Jun 19:ehag475. doi: 10.1093.
    

    >> Share

    
    
39. KANG J, Han M, Wang L
    Fulminant myocarditis complicated by acute myocardial infarction.
    Eur Heart J. 2026 Jun 23:ehag366. doi: 10.1093.
    

    >> Share

    
    

    
    Heart

40. WATANABE A, Miyamoto Y, Ueyama HA, Inoue K, et al
    Percutaneous ventricular assist devices for percutaneous coronary interventions in older patients with heart failure: a target trial emulation.
    Heart. 2025 Nov 11:heartjnl-2025-326949. doi: 10.1136/heartjnl-2025-326949.
    

    >> Share

    
    
41. HADJIS A, De Marco C, Raymond JM, Sapp JL, et al
    Ventricular tachycardia ablation in ischaemic cardiomyopathy: who, when and how?
    Heart. 2026;112:771-780.
    

    >> Share

    
    

    
    Hypertension

42. ELTON-BOTT NWY, Cole TJ, Young MJ
    Role of Mineralocorticoid Receptors in Cardiovascular Disease.
    Hypertension. 2026 Jun 23. doi: 10.1161/HYPERTENSIONAHA.126.26235.
    

    >> Share

    
    

    
    Int J Cardiol

43. LENSELINK C, Lau YH, Huang W, Ewe SH, et al
    Clinical and artificial intelligence assessed echocardiographic predictors of outcomes after acute myocardial infarction.
    Int J Cardiol. 2026;460:134638.
    

    >> Share

    
    
44. SONAGLIONI A, Nicolosi GL
    Beyond pre-test probability: Refining chronic coronary disease risk stratification through chest wall conformation and stress echocardiography.
    Int J Cardiol. 2026 Jun 24:134639. doi: 10.1016/j.ijcard.2026.134639.
    

    >> Share

    
    

    
    J Am Coll Cardiol

45. KRUMHOLZ HM
    When the Same Patient Is Not the Same Patient: The Will Rogers Phenomenon in Contemporary Cardiovascular Care.
    J Am Coll Cardiol. 2026;87:3381-3383.
    

    >> Share

    
    
46. SHI H, Cheng S, Sun D, Han Y, et al
    Associations Between PM(2.5) Components and Cardiovascular Diseases: A Cohort Study of 0.5 Million Chinese Adults.
    J Am Coll Cardiol. 2026 Jun 16:S0735-1097(26)06359.
    

    >> Share

    
    

    
    J Cardiovasc Pharmacol

47. CHEN Z, Li G, Tang X, Liu X, et al
    Cardiovascular Adverse Events Associated with Immune Checkpoint Inhibitors from the Perspective of Gut Microecology: Potential Roles and Research Advances of the Gut Microbiota.
    J Cardiovasc Pharmacol. 2026 Jun 5. doi: 10.1097/FJC.0000000000001842.
    

    >> Share

    
    

    
    J Electrocardiol

48. DE ALENCAR JN
    What the electrocardiogram is being asked to detect in acute myocardial infarction: The case for the OMI/NOMI paradigm.
    J Electrocardiol. 2026;98:154395.
    

    >> Share

    
    

    
    J Mol Cell Cardiol

49. SOLGA I, Gotzmann L, Yogathasan V, Wischmann P, et al
    Large extracellular vesicles derived from red blood cells in coronary artery disease patients with anemia promote endothelial dysfunction.
    J Mol Cell Cardiol. 2026 Jun 26:S0022-2828(26)00095.
    

    >> Share

    
    

    
    J Thorac Cardiovasc Surg

50. BEUKERS SHQ, Jacobs S, Klein P, Bronkers G, et al
    The first prospective Safety And efFectiveness trial of the excimer laser assisted non-occlusive anastomosis system in Coronary Artery Bypass grafting.
    J Thorac Cardiovasc Surg. 2026 Jun 22:S0022-5223(26)01126.
    

    >> Share

    
    
51. KACZOROWSKI DJ, Takeda K, Atluri P, Cevasco M, et al
    Erratum to 2025 American Association for Thoracic Surgery (AATS) Expert Consensus Document: Surgical management of acute myocardial infarction and associated complications: The Journal of Thoracic and Cardiovascular Surgery, Volume 170, Issue 5, 2025,
    J Thorac Cardiovasc Surg. 2026 Jun 22:S0022-5223(26)00885.
    

    >> Share

    
    

    
    JAMA

52. STEG PG
    Primary Composite Outcome Corrected in a Trial of Transfusion Strategy in Myocardial Infarction and Anemia.
    JAMA. 2026 Jun 24. doi: 10.1001/jama.2026.10006.
    

    >> Share

    
    

    
    Mayo Clin Proc

53. WU JY, Lee KW, Huang SC, Chang HY, et al
    Association Between Angiotensin Receptor Blocker Use and Cardiovascular Outcomes Compared With Angiotensin-Converting Enzyme Inhibitors in Patients With Atherosclerotic Cardiovascular Disease: A Real-World Cohort Study.
    Mayo Clin Proc. 2026 Jun 19:S0025-6196(26)18588.
    

    >> Share

    
    

    
    N Engl J Med

54. VIGNATI C, Galotta A, Pezzuto B
    Stopping Beta-Blockers after Myocardial Infarction.
    N Engl J Med. 2026;394:2483-2484.
    

    >> Share

    
    
55. PIVATO CA, Pensato U, Stefanini GG
    Stopping Beta-Blockers after Myocardial Infarction.
    N Engl J Med. 2026;394:2484.
    

    >> Share

    
    
56. MESSERLI FH, Maqsood MH, Bangalore S
    Stopping Beta-Blockers after Myocardial Infarction.
    N Engl J Med. 2026;394:2484-2485.
    

    >> Share

    
    
57. WU W, Xu G, Gao X
    Stopping Beta-Blockers after Myocardial Infarction.
    N Engl J Med. 2026;394:2485.
    

    >> Share

    
    
58. CHOI KH, Kang D, Hahn JY
    Stopping Beta-Blockers after Myocardial Infarction. Reply.
    N Engl J Med. 2026;394:2485-2486.
    

    >> Share

    
    
59. 
    Immediate or Deferred Nonculprit-Lesion PCI in Myocardial Infarction.
    N Engl J Med. 2026;394:2488.
    

    >> Share

    
    

    
    PLoS One

60. KOKORELIAS KM, Huang YQ, Harris MT, Hoang PM, et al
    Prevalence of heart failure and coronary artery disease in older adults experiencing homelessness: A systematic review and meta-analysis protocol with a consultative exercise.
    PLoS One. 2026;21:e0345868.
    

    >> Share

    
    

    
    Prog Cardiovasc Dis

61. KOO BK
    COVID-19 and coronary atherosclerosis: Unmasking and accelerating?
    Prog Cardiovasc Dis. 2026 Jun 24:S0033-0620(26)00064.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share